Hologic Ownership (HOLX)

USA |NASDAQ |USD

Hologic Ownership Highlights

Hologic (NASDAQ:HOLX) is owned by 96.97% institutional shareholders and by 0.71% insiders. The rest is owned by the public.

The largest institutional owner of Hologic is "T. Rowe Price Associates, Inc.", owning 16.52% of the company's total share outstanding.

The largest mutual fund owner of Hologic is "T. Rowe Price Mid-Cap Growth", owning 5.26% of the company's total share outstanding.

Institutional Owners of Hologic

The top 10 institutional shareholders of Hologic together own 133.92M shares, representing 53.57% of Hologic's total shares outstanding.

The table below contains a list of the top institutional shareholders of HOLX.

Name Shares % of Shares Out % of Total Assets Managed Change (Shares) Change %
T. Rowe Price Associates, Inc. 41.30M 16.52% 0.28% -650.62K -1.55%
Vanguard Group Inc 27.50M 11.00% 0.05% -100.54K -0.36%
BlackRock Inc 21.89M 8.76% 0.04% 532.53K 2.49%
State Street Corporation 11.33M 4.53% 0.04% 423.50K 3.88%
FMR Inc 9.01M 3.61% 0.05% -4.18M -31.70%
Wellington Management Company LLP 6.26M 2.50% 0.08% -308.93K -4.71%
Geode Capital Management, LLC 5.79M 2.32% 0.05% 398.92K 7.40%
Parnassus Investments, LLC 4.27M 1.71% 0.63% 127.02K 3.07%
BNP Paribas Investment Partners SA 3.45M 1.38% 0.88% 144.60K 4.37%
Northern Trust Corp 3.11M 1.25% 0.04% -61.75K -1.94%

Mutual Funds Holding Hologic

The top 10 mutual funds shareholders of Hologic together hold 50.82M shares, representing 20.33% of Hologic's total shares outstanding.

The table below contains a list of the top mutual funds holding HOLX.

Owner Name Shares % of Shares Out % of Total Assets Managed Change (Shares) Change %
T. Rowe Price Mid-Cap Growth 13.15M 5.26% 3.06% -15.90K -0.12%
Vanguard Total Stock Mkt Idx Inv 7.24M 2.89% 0.04% 24.37K 0.34%
Vanguard Mid Cap Index Institutional 5.68M 2.27% 0.28% -81.06K -1.41%
Vanguard 500 Index Investor 5.47M 2.19% 0.05% -32.24K -0.59%
Parnassus Mid-Cap 4.27M 1.71% 4.27% - -
T. Rowe Price Capital Appreciation 3.97M 1.59% 0.58% 1.25M 45.74%
T. Rowe Price Health Sciences 3.17M 1.27% 1.39% 266.28K 9.17%
SPDR® S&P 500 ETF Trust 2.78M 1.11% 0.05% 36.16K 1.32%
Fidelity® 500 Index 2.60M 1.04% 0.05% 39.16K 1.53%
T. Rowe Price Instl Mid-Cap Equity Gr 2.49M 1.00% 3.14% 7.80K 0.31%

Insider Transactions

Transaction Date Insider Name Buy/ Sell Number of Shares Price Shares Held After Transaction Details
Feb 24, 2022 Sean S Daugherty Sell 2.18K $71.14 Details
Nov 19, 2021 Benjamin Jordan Cohn Sell 2.57K $75.79 Details
May 10, 2021 Sean S. Daugherty Sell 4.00K $65.02 26.61K Details
Feb 4, 2021 Benjamin Jordan Cohn Sell 8.40K $84.31 Details
Dec 10, 2020 Kevin R Thornal Sell 16.87K $73.99 40.85K Details
Nov 17, 2020 Benjamin Jordan Cohn Sell 5.00K $72.58 23.29K Details
Aug 3, 2020 Benjamin Jordan Cohn Sell 4.92K $71.24 Details
Jun 30, 2020 Peter J. Valenti III Sell 10.49K $54.07 Details
May 22, 2020 Peter J. Valenti III Sell 10.49K $51.82 Details
May 22, 2020 Sally Crawford Sell 31.95K $51.99 126.85K Details

Hologic Ownership: A Close Look

Hologic's Largest Institutional Shareholders

The largest institutional shareholders of Hologic are "T. Rowe Price Associates, Inc.", "Vanguard Group Inc" and "BlackRock Inc". Those three own together 36.28% of HOLX's total shares outstanding.

1. T. Rowe Price Associates, Inc.

T. Rowe Price Associates, Inc. is a financial sevices holding company that provides global investment management services to investors worlwide. The compan provies U.S mutual funds, subadvised funds, separately managed account and other products. The company’s assets under management totaled US$1.5 tillion.

The company owns 41.30M shares of Hologic, representing 16.52% of HOLX's total share outstanding. Using the last stock closing price of $71.40, T. Rowe Price Associates, Inc.'s current total stake in Hologic is worth $2.95B.

2. Vanguard Group Inc

Vanguard is one of the world's largest investment companies, offering a large selection of low-cost mutual funds, ETFs, advice, and related services. As of January 31, 2021, Vanguard's asset under management totaled US$7.2 trillion. The company manages 209 U.S. funds and about 232 additional funds in markets outside the United States. Vanguard has more than 30 million investors, in about 170 countries.

The company owns 27.50M shares of Hologic, representing 11.00% of HOLX's total share outstanding. Using the last stock closing price of $71.40, Vanguard Group Inc's current total stake in Hologic is worth $1.96B.

3. BlackRock Inc (NYSE:BLK)

BlackRock is one of the world’s leading asset management firms and a premier provider of investment management, risk management and advisory services to institutional, intermediary and retail clients worldwide. The company offers a range of solutions — from rigorous fundamental and quantitative active management approaches aimed at maximizing outperformance to highly efficient indexing strategies designed to gain broad exposure to the world's capital markets. As of 31 December 2020, BlackRock’s assets under management totaled US$8.68 trillion.

The company owns 21.89M shares of Hologic, representing 8.76% of HOLX's total share outstanding. Using the last stock closing price of $71.40, BlackRock Inc's current total stake in Hologic is worth $1.56B.

Blackrock Inc is a public company, traded on the NYSE stock market.

Hologic's Largest Mutual Fund Holders

The largest mutual fund holders of Hologic are "T. Rowe Price Mid-Cap Growth", "Vanguard Total Stock Mkt Idx Inv" and "Vanguard Mid Cap Index Institutional". Together these mutual funds hold 10.43% of Hologic's total share outstanding.

"T. Rowe Price Mid-Cap Growth" holds 13.15M shares, representing 5.26% of Hologic's total shares outstanding.

"Vanguard Total Stock Mkt Idx Inv" holds 7.24M shares, representing 2.89% of Hologic's total shares outstanding.

"Vanguard Mid Cap Index Institutional" holds 5.68M shares, representing 2.27% of Hologic's total shares outstanding.